Storage conditions for stability testing of pharmaceuticals in hot and humid regions

Drug Development and Industrial Pharmacy

Volumn 33, Issue 4, 2007, Pages 393-401

  Bott, Rubiana F ^a   Oliveira, Wanderley P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Climatic zones; Mean kinetic temperature; Relative humidity; Stability testing

Indexed keywords

BRAZIL; CLIMATE; DEVELOPING COUNTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; HUMIDITY; REVIEW; WEATHER; WORLD HEALTH ORGANIZATION;

BRAZIL; DRUG INDUSTRY; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; HEAT; HUMANS; HUMIDITY; PHARMACEUTICAL PREPARATIONS; TEMPERATURE; TROPICAL CLIMATE; WORLD HEALTH ORGANIZATION;

EID: 34249298342     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600975022     Document Type: Review

References (30)

1. Babu, J. R., & Pandit, J. K. (1999). Effects of aging on the dissolution stability of glibenclamide b-cyclodextrin complex. Drug Develop. Ind. Pharm., 25, 1215-1219.
2. Brasil. Resolução - RE no 560 de 2 de abril de 2002. Guia para a realização de estudos de estabilidade. Agência Nacional de Vigilância Sanitária. Disponível em: http://www.anvisa.gov.br/legis/resol/2002/56002re.htm. 2002. Acesso em 15 de fevereiro de 2003.
3. Brasil. Resolução - RE no 398 de 12 de novembro de 2004. Guia para a realização de estudos de estabilidade. Agência Nacional de Vigilância Sanitária. 2004. Disponível em: http://e-legis.bvs.br/ leisref/public/showAct.php?mode=PRINT_VERSION&id= 13227.
4. Brasil. Resolução - RE no 1, de 29 de julho de 2005. Guia para a realização de estudos de estabilidade. Agência Nacional de Vigilância Sanitária. 2005. Disponível em: http://e-legis.bvs.br/leisref/public/showAct.php?id=18109&mode= PRINT_VERSION.
5. Carstensen, J. T. (1995). Interactions of moisture with solids. In Drug Stability: Principles And Practices, University of Wisconsin - Madison, Marcel Dekker: New York; 281-303.
6. Florence, A. T., & Attwood, D. (2003). Estabilidade de drogas. In Princípios Físicos Químicos em Farmácia, Editora da Universia de São Paulo (EDUSP): São Paulo, 155-218 (in Portuguese).
7. Grimm, W. (1986). Storage conditions for stability testing-long term testing and stress tests. Drugs Made in Germany, 29, 39-47.
8. Grimm, W. (1993). Storage conditions for stability testing in the EC, Japan and USA; The most important market for drug products. Drug Develop. Ind. Pharm., 19(20), 2795-2830.
9. Grimm, W. (1998). Extension of the international conference on harmonization tripartite guideline for stability testing of new drug substances and products to countries of climatic zones III and IV. Drug Develop. Ind. Pharm., 24(4), 313-325.
10. Haynes, J. D. (1971). Worldwide virtual temperature for product stability testing. J. Pharm. Sci., 60(6), 927-929.
11. Hogerzeil H. V., De Goeje, M.J., & Abu-Reid, I.O. (1991). Stability of essential drugs in Sudan. Lancet, 338, 754-755.
12. Hüttenrauch, R. (1987). Physico-chemical changed from a molecular-galenical view point. In Stability Testing of Drug Products; Grimm, W., Ed.; Wissenschaftliche Verlagsgesellschaft mbH: Stuttgart, 17-32.
13. IBGE (2000). Atlas Do Censo Demográfico. IBGE: Brazil.
14. ICHQ1F (2004). Guidance for Industry. Stability Data Package for Registration Applications in Climatic Zones III and IV.
15. Kommanaboyina, B., & Rhodes, C.T. (1999). Trends in stability testing, with emphasis on stability during distribution and storage. Drug Develop. Ind. Pharm., 25, 857-868.
16. Matthews, R. B. (1999). Regulatory aspects of stability testing in Europe. Drug Develop. Ind. Pharm., 25, 831-856.
17. Nazerali, H., Muchemwa, T., & Hogerzeil, H. V. (1996). The quality and stability of essential drugs in tropical climates. Inland Stability Study Zimbabwe, WHO/DAP/94.16.
18. Oliveira, J. (2003). Brazil: Market Overview of Drugs and Pharmaceuticals. US & Foreign Commercial Service and US Department of State. http://strategis.ic.gc.ca/epic/internet/inimr-ri.nsf/en/gr118345e.html, Accessed in April 2006.
19. Palmeira Filho, P. L., & Pan, S. S. K. (2003). Cadeia farmacêutica no Brasil: Avaliação preliminar e perspectivas. BNDES Setorial, Rio de Janeiro, 18, 13-22 (in Portuguese).
20. Pandit, J. K., Tripathi, M. K., & Babu, J. R. (1997). Effects of disintegrants on the dissolution stability of solid oral dosage forms. Pharmazie, 52, 538-540.
21. Peixoto, J. P., & Oort, A. H. (1992). Physics of Climate, AIP Press: New York.
22. Risha, P. G., Shewiyo, D., Msami, A., Masuki, G., Vergote, G., Vervaet, C., & Remon, J.P. (2002). In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop. Med. Int. Health, 7, 701-707.
23. Risha, P. G., Vervaet, C., Vergote, G., Van Bortel, L., & Remon, J. P. (2003). Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. Eur. J. Clinic. Pharmacol.,59, 135-141.
24. Saab, W. G. L., & Ribeiro, R. M. (2001). Um panorama do varejo de farmácias e drogarias no Brasil, Área de Operações Industriais 2 (AO2). Gerência Setorial de Comércio e Serviço, 25, (in Portuguese). 5 p. Disponívem em: www.bndes.gov.br/conhecimento/setorial/get4is25.pdf
25. Saville, D. J. (2001). Influence of storage on in vitro release of ibuprofen from sugar coated tablets. Int. J. Pharm., 224, 39-49.
26. Stull, R. B. (1988). An Introduction to Boundary Layer Meteorology. Kluwer Academic Publishers: Amsterdam.
27. Taylor, J. (2001). Recommendations on the control and monitoring of storage and transportation temperatures of medicinal products. Pharma. J., 267(28), 128-131.
28. Young, W. R. (1990). Accelerated temperature pharmaceutical product stability determinations. Drug Develop. Ind. Pharm., 16(4), 551-569.
29. WHO (2004a). Aspects of the quality assurance. WHO Drug Information 18(2), 113-116 (available in: http://www.who.int/druginformation/ vol18num2_2004/DI18-2.pdf).
30. WHO (2004b). Stability studies in a global environment. Geneva meeting. Working document QAS/05.146 with comments, 10 pp (available in http://www.who.int/medicines/services/expertcommittees/pharmprep/ QAS05_146Stabilitywithcomments.pdf.